Need a specific person's email?
Browse Eikonizo Therapeutics's employee directory (about 13 employees) and reveal verified emails free.
Eikonizo Therapeutics's most common email format is First.Last@eikonizo.com (ex. John.Doe@eikonizo.com), used for 96% of eikonizo.com addresses. Eikonizo Therapeutics uses 2 email patterns.
| Format | Example | Share of eikonizo.com |
|---|---|---|
| First.Last@eikonizo.comMost common | John.Doe@eikonizo.com | |
| First.Middle@eikonizo.com | John.Michael@eikonizo.com |
Browse Eikonizo Therapeutics's employee directory (about 13 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
Eikonizo Therapeutics is a biotechnology research company located at 700 Main Street, North Cambridge, Massachusetts 02139, United States, with 11-50 employees. The company develops brain-penetrant small molecules and uses in vivo target engagement techniques to accelerate the identification of therapeutics. Its initial program is focused on a disease-modifying therapeutic for neurodegenerative diseases. In December 2024, Novo Nordisk A/S invested in Eikonizo, and related governance and leadership appointments were announced, indicating external collaboration. More information is available on the company website at https://eikonizo.com.
Most common format
First.Last@eikonizo.com
Example: John.Doe@eikonizo.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.